Holen Sie sich die Stockscreener-App
0.9934
5.39%
-0.0566
Finanzdaten der Annovis Bio Inc-Aktie (ANVS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
| Operating Expenses |
20.18%
14.38
|
18.01 | 9.7061 | 7.435 | 6.2715 |
| Operating Income/Loss |
20.18%
-14.38
|
-18.01 | -9.7061 | -7.435 | -6.2715 |
| Nonoperating Income/Loss |
209.19%
-0.4431
|
0.4058 | -0.1283 | 0.1723 | 0.0514 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Net Income/Loss |
15.82%
-14.82
|
-17.61 | -9.8344 | -7.2627 | -6.2201 |
| Basic Average Shares |
34.73%
37.52
|
27.85 | - | 19.69 | 19.49 |
| Diluted Average Shares |
34.73%
37.52
|
27.85 | - | 19.69 | 19.49 |
| Basic Earnings Per Share |
36.51%
-0.40
|
-0.63 | - | -0.37 | -0.32 |
| Diluted Earnings Per Share |
36.51%
-0.40
|
-0.63 | - | -0.37 | -0.32 |
4.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):